| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.36e-05 | 18 | 63 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.42e-05 | 129 | 63 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 5.85e-05 | 4 | 63 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 9.74e-05 | 5 | 63 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.14e-04 | 151 | 63 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.26e-04 | 31 | 63 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.46e-04 | 6 | 63 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.53e-04 | 33 | 63 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.89e-04 | 758 | 63 | 9 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.90e-04 | 459 | 63 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.37e-04 | 465 | 63 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | gated channel activity | 6.38e-04 | 334 | 63 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 7.33e-04 | 343 | 63 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 7.64e-04 | 627 | 63 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 8.12e-04 | 793 | 63 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.00e-03 | 140 | 63 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | Hsp70 protein binding | 1.04e-03 | 63 | 63 | 3 | GO:0030544 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.11e-03 | 664 | 63 | 8 | GO:0008324 | |
| GeneOntologyMolecularFunction | channel activity | 1.29e-03 | 525 | 63 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.31e-03 | 526 | 63 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 1.68e-03 | 161 | 63 | 4 | GO:0051087 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 2.46e-03 | 435 | 63 | 6 | GO:0004857 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 2.65e-03 | 596 | 63 | 7 | GO:0140678 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | FZR1 URI1 CAPN3 PDE4DIP LRRK2 ACTN4 NIBAN2 SPEN DNAJC2 TBL1X NUFIP1 | 3.18e-03 | 1356 | 63 | 11 | GO:0060090 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.23e-03 | 193 | 63 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 3.27e-03 | 27 | 63 | 2 | GO:0004683 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.48e-03 | 197 | 63 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | FZR1 URI1 ATP6V1H TIMP2 CTSC CAPN3 LRRK2 UGT1A9 SERPINB1 RABGEF1 PABIR3 | 4.47e-03 | 1418 | 63 | 11 | GO:0030234 |
| GeneOntologyBiologicalProcess | response to calcium ion | 6.62e-07 | 161 | 64 | 7 | GO:0051592 | |
| GeneOntologyBiologicalProcess | response to metal ion | 5.13e-06 | 415 | 64 | 9 | GO:0010038 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 2.61e-05 | 509 | 64 | 9 | GO:0006816 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 2.77e-05 | 392 | 64 | 8 | GO:0070588 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA2D1 IL16 ATP6V1H CACNA2D2 GIMAP5 CAPN3 UBR3 ACTN4 RYR2 RYR3 TFRC ITPR3 NEDD4 | 4.60e-05 | 1157 | 64 | 13 | GO:0006812 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA2D1 IL16 CACNA2D2 GIMAP5 CAPN3 UBR3 ACTN4 RYR2 RYR3 TFRC ITPR3 NEDD4 | 5.02e-05 | 1000 | 64 | 12 | GO:0030001 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 5.71e-05 | 217 | 64 | 6 | GO:0097553 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA2D1 IL16 ATP6V1H CACNA2D2 GIMAP5 CAPN3 UBR3 ACTN4 GRIK2 RYR2 RYR3 TFRC ITPR3 NEDD4 | 6.50e-05 | 1374 | 64 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of cell activation | IL16 GIMAP5 CTSC PARP3 CAPN3 LRRK2 RABGEF1 TNFAIP3 IL7R TFRC | 1.04e-04 | 756 | 64 | 10 | GO:0050865 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 1.07e-04 | 611 | 64 | 9 | GO:0030003 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA2D1 ATP6V1H CACNA2D2 GIMAP5 CAPN3 UBR3 ACTN4 RYR2 RYR3 ITPR3 NEDD4 | 1.14e-04 | 922 | 64 | 11 | GO:0098662 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 1.22e-04 | 622 | 64 | 9 | GO:0006873 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA2D1 ATP6V1H CACNA2D2 GIMAP5 CAPN3 UBR3 ACTN4 RYR2 RYR3 ITPR3 NEDD4 | 1.37e-04 | 942 | 64 | 11 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 1.38e-04 | 493 | 64 | 8 | GO:0010959 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA2D1 ATP6V1H CACNA2D2 GIMAP5 CAPN3 UBR3 ACTN4 GRIK2 RYR2 RYR3 ITPR3 NEDD4 | 1.42e-04 | 1115 | 64 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | protein catabolic process | FZR1 TIMP2 CTSC CAPN3 LRRK2 SERPINB1 UBR3 APOB TNFAIP3 TTC3 TBL1X NEDD4 | 1.42e-04 | 1115 | 64 | 12 | GO:0030163 |
| GeneOntologyBiologicalProcess | regulation of monoatomic cation transmembrane transport | 1.72e-04 | 380 | 64 | 7 | GO:1904062 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | DMXL2 ATP6V1H CAPN3 LRRK2 SERPINB1 GRIK2 RYR2 IL7R RYR3 TFRC ITPR3 | 1.96e-04 | 981 | 64 | 11 | GO:0019725 |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 2.06e-04 | 174 | 64 | 5 | GO:1904064 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process | 2.61e-04 | 407 | 64 | 7 | GO:0042176 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA2D1 ATP6V1H CACNA2D2 GIMAP5 CAPN3 UBR3 ACTN4 RYR2 RYR3 ITPR3 NEDD4 | 2.67e-04 | 1017 | 64 | 11 | GO:0098660 |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | 2.76e-04 | 694 | 64 | 9 | GO:0002694 | |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 3.00e-04 | 42 | 64 | 3 | GO:0060402 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transport | 3.02e-04 | 417 | 64 | 7 | GO:0034765 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 3.10e-04 | 705 | 64 | 9 | GO:0055080 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA biosynthetic process | 3.22e-04 | 43 | 64 | 3 | GO:2000279 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 3.24e-04 | 192 | 64 | 5 | GO:0034767 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 3.51e-04 | 717 | 64 | 9 | GO:0050801 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 3.67e-04 | 109 | 64 | 4 | GO:1904427 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 3.99e-04 | 577 | 64 | 8 | GO:0043269 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | 4.57e-04 | 589 | 64 | 8 | GO:0034762 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 4.71e-04 | 449 | 64 | 7 | GO:0050867 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 4.92e-04 | 323 | 64 | 6 | GO:0051924 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 5.12e-04 | 11 | 64 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | positive regulation of microglial cell activation | 5.12e-04 | 11 | 64 | 2 | GO:1903980 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 5.58e-04 | 462 | 64 | 7 | GO:0002460 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport | 5.79e-04 | 218 | 64 | 5 | GO:1903169 | |
| GeneOntologyBiologicalProcess | cellular response to metal ion | 5.91e-04 | 219 | 64 | 5 | GO:0071248 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process | 7.09e-04 | 228 | 64 | 5 | GO:0045732 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 7.23e-04 | 13 | 64 | 2 | GO:0009812 | |
| GeneOntologyBiologicalProcess | regulation of production of molecular mediator of immune response | 7.52e-04 | 231 | 64 | 5 | GO:0002700 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 8.12e-04 | 235 | 64 | 5 | GO:0002822 | |
| GeneOntologyBiologicalProcess | cell activation | CFH IL16 GIMAP5 CTSC PARP3 CAPN3 LRRK2 RABGEF1 TNFAIP3 IL7R TFRC NEDD4 | 8.39e-04 | 1356 | 64 | 12 | GO:0001775 |
| GeneOntologyBiologicalProcess | negative regulation of vascular endothelial growth factor receptor signaling pathway | 8.42e-04 | 14 | 64 | 2 | GO:0030948 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 8.42e-04 | 14 | 64 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | 8.58e-04 | 497 | 64 | 7 | GO:0002697 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 1.08e-03 | 65 | 64 | 3 | GO:0098815 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 1.10e-03 | 146 | 64 | 4 | GO:0051209 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 1.11e-03 | 16 | 64 | 2 | GO:0007158 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 1.11e-03 | 252 | 64 | 5 | GO:0002819 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 1.13e-03 | 147 | 64 | 4 | GO:0051283 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 1.16e-03 | 148 | 64 | 4 | GO:1902414 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 1.19e-03 | 149 | 64 | 4 | GO:0051282 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 1.19e-03 | 256 | 64 | 5 | GO:0032412 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 7.39e-06 | 88 | 64 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.61e-05 | 114 | 64 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | vesicle lumen | 6.84e-05 | 332 | 64 | 7 | GO:0031983 | |
| GeneOntologyCellularComponent | presynapse | PCSK1 CACNA2D1 DMXL2 ATP6V1H NRXN3 NRXN1 CACNA2D2 LRRK2 GRIK2 NUFIP1 ITPR3 | 7.08e-05 | 886 | 64 | 11 | GO:0098793 |
| GeneOntologyCellularComponent | presynaptic active zone | 7.20e-05 | 141 | 64 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | somatodendritic compartment | PCSK1 CFH URI1 NRXN1 TIMP2 SACS LRRK2 RABGEF1 APOB GRIK2 TTLL7 ITPR3 NEDD4 | 7.39e-05 | 1228 | 64 | 13 | GO:0036477 |
| GeneOntologyCellularComponent | calcium channel complex | 7.42e-05 | 73 | 64 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 9.62e-05 | 78 | 64 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 3.78e-04 | 46 | 64 | 3 | GO:0005790 | |
| GeneOntologyCellularComponent | secretory granule lumen | 4.74e-04 | 325 | 64 | 6 | GO:0034774 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | 5.14e-04 | 330 | 64 | 6 | GO:0060205 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 6.94e-04 | 230 | 64 | 5 | GO:0098562 | |
| GeneOntologyCellularComponent | cation channel complex | 7.65e-04 | 235 | 64 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | neuronal cell body | 9.52e-04 | 835 | 64 | 9 | GO:0043025 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 1.08e-03 | 147 | 64 | 4 | GO:0030665 | |
| GeneOntologyCellularComponent | dendrite | 1.15e-03 | 858 | 64 | 9 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.17e-03 | 860 | 64 | 9 | GO:0097447 | |
| GeneOntologyCellularComponent | Z disc | 1.19e-03 | 151 | 64 | 4 | GO:0030018 | |
| GeneOntologyCellularComponent | secretory vesicle | PCSK1 CACNA2D1 DMXL2 ATP6V1H TIMP2 AGL CTSC LRRK2 SERPINB1 ACTN4 ITPR3 | 1.30e-03 | 1246 | 64 | 11 | GO:0099503 |
| GeneOntologyCellularComponent | side of membrane | 1.32e-03 | 875 | 64 | 9 | GO:0098552 | |
| GeneOntologyCellularComponent | myofibril | 1.49e-03 | 273 | 64 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.59e-03 | 277 | 64 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.61e-03 | 164 | 64 | 4 | GO:0098982 | |
| GeneOntologyCellularComponent | I band | 1.68e-03 | 166 | 64 | 4 | GO:0031674 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 1.83e-03 | 79 | 64 | 3 | GO:0030669 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.94e-03 | 290 | 64 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | cell body | 1.99e-03 | 929 | 64 | 9 | GO:0044297 | |
| GeneOntologyCellularComponent | triglyceride-rich plasma lipoprotein particle | 2.44e-03 | 24 | 64 | 2 | GO:0034385 | |
| GeneOntologyCellularComponent | very-low-density lipoprotein particle | 2.44e-03 | 24 | 64 | 2 | GO:0034361 | |
| GeneOntologyCellularComponent | sarcolemma | 2.75e-03 | 190 | 64 | 4 | GO:0042383 | |
| GeneOntologyCellularComponent | secretory granule | 3.58e-03 | 1014 | 64 | 9 | GO:0030141 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 3.68e-03 | 101 | 64 | 3 | GO:0045334 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 4.27e-03 | 215 | 64 | 4 | GO:0030662 | |
| GeneOntologyCellularComponent | perikaryon | 4.86e-03 | 223 | 64 | 4 | GO:0043204 | |
| GeneOntologyCellularComponent | coated vesicle | 4.89e-03 | 360 | 64 | 5 | GO:0030135 | |
| GeneOntologyCellularComponent | high-density lipoprotein particle | 5.14e-03 | 35 | 64 | 2 | GO:0034364 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 5.24e-03 | 523 | 64 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | neuronal dense core vesicle | 5.44e-03 | 36 | 64 | 2 | GO:0098992 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 6.00e-03 | 378 | 64 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 6.01e-03 | 237 | 64 | 4 | GO:0030136 | |
| GeneOntologyCellularComponent | dendrite cytoplasm | 6.36e-03 | 39 | 64 | 2 | GO:0032839 | |
| GeneOntologyCellularComponent | endocytic vesicle | 6.40e-03 | 384 | 64 | 5 | GO:0030139 | |
| GeneOntologyCellularComponent | vacuole | 6.52e-03 | 913 | 64 | 8 | GO:0005773 | |
| GeneOntologyCellularComponent | transporter complex | 6.66e-03 | 550 | 64 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | sarcomere | 7.14e-03 | 249 | 64 | 4 | GO:0030017 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 7.34e-03 | 42 | 64 | 2 | GO:0070971 | |
| GeneOntologyCellularComponent | lipoprotein particle | 8.04e-03 | 44 | 64 | 2 | GO:1990777 | |
| GeneOntologyCellularComponent | plasma lipoprotein particle | 8.04e-03 | 44 | 64 | 2 | GO:0034358 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 8.39e-03 | 45 | 64 | 2 | GO:0033017 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 8.76e-03 | 46 | 64 | 2 | GO:0005891 | |
| GeneOntologyCellularComponent | protein-lipid complex | 9.13e-03 | 47 | 64 | 2 | GO:0032994 | |
| Domain | RIH_assoc | 7.62e-07 | 6 | 64 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 7.62e-07 | 6 | 64 | 3 | IPR013662 | |
| Domain | RIH_dom | 7.62e-07 | 6 | 64 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.62e-07 | 6 | 64 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.62e-07 | 6 | 64 | 3 | IPR015925 | |
| Domain | - | 7.62e-07 | 6 | 64 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.62e-07 | 6 | 64 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 7.62e-07 | 6 | 64 | 3 | PF08709 | |
| Domain | MIR | 4.53e-06 | 10 | 64 | 3 | PS50919 | |
| Domain | MIR | 4.53e-06 | 10 | 64 | 3 | PF02815 | |
| Domain | MIR | 4.53e-06 | 10 | 64 | 3 | SM00472 | |
| Domain | MIR_motif | 4.53e-06 | 10 | 64 | 3 | IPR016093 | |
| Domain | Ryanrecept_TM4-6 | 3.46e-05 | 3 | 64 | 2 | IPR009460 | |
| Domain | RyR | 3.46e-05 | 3 | 64 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 3.46e-05 | 3 | 64 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 3.46e-05 | 3 | 64 | 2 | PF06459 | |
| Domain | Ryan_recept | 3.46e-05 | 3 | 64 | 2 | IPR013333 | |
| Domain | VGCC_alpha2 | 6.90e-05 | 4 | 64 | 2 | PF08473 | |
| Domain | VDCC_a2/dsu | 6.90e-05 | 4 | 64 | 2 | IPR013680 | |
| Domain | VWA_N | 1.15e-04 | 5 | 64 | 2 | IPR013608 | |
| Domain | VWA_N | 1.15e-04 | 5 | 64 | 2 | PF08399 | |
| Domain | Znf_A20 | 2.40e-04 | 7 | 64 | 2 | IPR002653 | |
| Domain | ZF_A20 | 2.40e-04 | 7 | 64 | 2 | PS51036 | |
| Domain | zf-A20 | 2.40e-04 | 7 | 64 | 2 | PF01754 | |
| Domain | Syndecan | 2.40e-04 | 7 | 64 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 2.40e-04 | 7 | 64 | 2 | IPR027789 | |
| Domain | ZnF_A20 | 2.40e-04 | 7 | 64 | 2 | SM00259 | |
| Domain | Neurexin-like | 1.02e-03 | 14 | 64 | 2 | IPR003585 | |
| Domain | 4.1m | 1.02e-03 | 14 | 64 | 2 | SM00294 | |
| Domain | ARM-type_fold | 1.06e-03 | 339 | 64 | 6 | IPR016024 | |
| Domain | N2O_reductase_N | 1.18e-03 | 15 | 64 | 2 | IPR011045 | |
| Domain | THIOL_PROTEASE_CYS | 3.56e-03 | 26 | 64 | 2 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 3.84e-03 | 27 | 64 | 2 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 3.84e-03 | 27 | 64 | 2 | PS00639 | |
| Domain | Pept_cys_AS | 4.13e-03 | 28 | 64 | 2 | IPR000169 | |
| Domain | EF-hand_8 | 6.04e-03 | 34 | 64 | 2 | PF13833 | |
| Domain | ConA-like_dom | 6.75e-03 | 219 | 64 | 4 | IPR013320 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.15e-05 | 19 | 51 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 5.67e-05 | 21 | 51 | 3 | M47950 | |
| Pathway | BIOCARTA_MITR_PATHWAY | 1.27e-04 | 5 | 51 | 2 | M22065 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 1.45e-04 | 74 | 51 | 4 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 1.45e-04 | 74 | 51 | 4 | M16376 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 2.25e-04 | 33 | 51 | 3 | M39875 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 4.55e-04 | 9 | 51 | 2 | M3412 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 5.16e-04 | 103 | 51 | 4 | MM15196 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 5.32e-04 | 44 | 51 | 3 | M39845 | |
| Pubmed | 1.56e-10 | 6 | 64 | 4 | 30683685 | ||
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 23463619 | ||
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.18e-07 | 6 | 64 | 3 | 25966694 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.18e-07 | 6 | 64 | 3 | 16844763 | |
| Pubmed | 2.07e-07 | 7 | 64 | 3 | 11860456 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 3.31e-07 | 8 | 64 | 3 | 19033399 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22252987 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 37543682 | ||
| Pubmed | Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. | 3.33e-06 | 2 | 64 | 2 | 9430716 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 3.33e-06 | 2 | 64 | 2 | 21531043 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 16678258 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24285081 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 8898078 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19658047 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18586264 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 14550562 | ||
| Pubmed | Exome sequencing: an efficient diagnostic tool for complex neurodegenerative disorders. | 3.33e-06 | 2 | 64 | 2 | 23043354 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 14985349 | ||
| Pubmed | CFH DMXL2 SACS ZNF423 PDE4DIP RAI14 ACTN4 CAMK1 TTC3 TARBP1 RYR3 NUFIP1 | 3.42e-06 | 1285 | 64 | 12 | 35914814 | |
| Pubmed | 3.61e-06 | 497 | 64 | 8 | 23414517 | ||
| Pubmed | 6.87e-06 | 143 | 64 | 5 | 20424473 | ||
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 7.32e-06 | 67 | 64 | 4 | 16987237 | |
| Pubmed | CACNA2D1 DMXL2 NRXN1 PKP4 PDE4DIP RABGEF1 GRIK2 TTC3 TBL1X NEDD4 | 9.89e-06 | 963 | 64 | 10 | 28671696 | |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 9.99e-06 | 3 | 64 | 2 | 34133920 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 38891114 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18403125 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18434746 | ||
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 9.99e-06 | 3 | 64 | 2 | 29730765 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 30858964 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 9.99e-06 | 3 | 64 | 2 | 9204703 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 7876312 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 21881589 | ||
| Pubmed | Presynaptic α2δ subunits are key organizers of glutamatergic synapses. | 9.99e-06 | 3 | 64 | 2 | 33782113 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 28013231 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 16406382 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 31812984 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 9.99e-06 | 3 | 64 | 2 | 12213830 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 20080692 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 9.99e-06 | 3 | 64 | 2 | 12036300 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 9242641 | ||
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 9.99e-06 | 3 | 64 | 2 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 9.99e-06 | 3 | 64 | 2 | 29045040 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 31005376 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 38571813 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 35173587 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 9.99e-06 | 3 | 64 | 2 | 10788707 | |
| Pubmed | RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle. | 9.99e-06 | 3 | 64 | 2 | 15024040 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 9.99e-06 | 3 | 64 | 2 | 7621815 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18643873 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11159936 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 9.99e-06 | 3 | 64 | 2 | 7722633 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 9.99e-06 | 3 | 64 | 2 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 9.99e-06 | 3 | 64 | 2 | 11944992 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 9.99e-06 | 3 | 64 | 2 | 17035546 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 9.99e-06 | 3 | 64 | 2 | 25423136 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 9.99e-06 | 3 | 64 | 2 | 10473538 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 9.99e-06 | 3 | 64 | 2 | 4600883 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 7635066 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 35773961 | ||
| Pubmed | 1.88e-05 | 28 | 64 | 3 | 23006423 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 22100703 | ||
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 2.00e-05 | 4 | 64 | 2 | 14983056 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 18206662 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 19596051 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 32706374 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 2.00e-05 | 4 | 64 | 2 | 23413940 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 9384575 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 8786425 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 9607712 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 17347997 | ||
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 2.00e-05 | 4 | 64 | 2 | 32134527 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 17056143 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 23482488 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 2.00e-05 | 4 | 64 | 2 | 33888718 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 28472659 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 36709330 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 33060591 | ||
| Pubmed | Transsynaptic Modulation of Kainate Receptor Functions by C1q-like Proteins. | 3.32e-05 | 5 | 64 | 2 | 27133466 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 20537373 | ||
| Pubmed | A role for the ubiquitin ligase Nedd4 in membrane sorting of LAPTM4 proteins. | 3.32e-05 | 5 | 64 | 2 | 22096579 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 36205393 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 23918386 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 3.32e-05 | 5 | 64 | 2 | 18923512 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 23402298 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 3.32e-05 | 5 | 64 | 2 | 19011160 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 9223334 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.79e-05 | 38 | 64 | 3 | 30786075 | |
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 4.98e-05 | 6 | 64 | 2 | 26025922 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 4.98e-05 | 6 | 64 | 2 | 12827191 | |
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 4.98e-05 | 6 | 64 | 2 | 14592808 | |
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 19816407 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 19009018 | ||
| Interaction | CAMK1D interactions | 6.58e-07 | 54 | 62 | 5 | int:CAMK1D | |
| Interaction | TRIM23 interactions | 1.40e-05 | 360 | 62 | 8 | int:TRIM23 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.34e-05 | 3 | 51 | 2 | 287 | |
| GeneFamily | Apolipoproteins | 1.58e-03 | 21 | 51 | 2 | 405 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.43e-03 | 26 | 51 | 2 | 253 | |
| Coexpression | GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP | 9.23e-06 | 199 | 64 | 6 | M5365 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | CACNA2D1 URI1 NRXN1 SACS CTSC PKP4 ABCF2 RAI14 TARBP1 ZNF367 DNAJC2 TFRC NEDD4 | 2.94e-05 | 1407 | 64 | 13 | M14427 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 4.02e-05 | 856 | 64 | 10 | M4500 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | PCSK1 DMXL2 ATP6V1H NRXN1 SACS PDE4DIP CAMK1G ACOT2 TTC3 TARBP1 NUFIP1 TFRC | 4.25e-05 | 1248 | 64 | 12 | M17728 |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP | 6.95e-05 | 175 | 64 | 5 | M6723 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 9.52e-05 | 302 | 64 | 6 | MM16604 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 9.75e-05 | 440 | 64 | 7 | M39039 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP | 1.21e-04 | 197 | 64 | 5 | M8426 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | 1.23e-04 | 790 | 64 | 9 | M12490 | |
| Coexpression | GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP | 1.24e-04 | 198 | 64 | 5 | M5790 | |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP | 1.27e-04 | 199 | 64 | 5 | M4886 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN | 1.27e-04 | 199 | 64 | 5 | M9943 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 1.27e-04 | 199 | 64 | 5 | M7522 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 1.30e-04 | 200 | 64 | 5 | M8081 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_DC_UP | 1.30e-04 | 200 | 64 | 5 | M6271 | |
| Coexpression | GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP | 1.30e-04 | 200 | 64 | 5 | M7022 | |
| Coexpression | GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP | 1.30e-04 | 200 | 64 | 5 | M6606 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP | 1.30e-04 | 200 | 64 | 5 | M9598 | |
| Coexpression | GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP | 1.30e-04 | 200 | 64 | 5 | M9060 | |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 1.30e-04 | 200 | 64 | 5 | M78 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN | 1.30e-04 | 200 | 64 | 5 | M6018 | |
| Coexpression | GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 1.30e-04 | 200 | 64 | 5 | M6057 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | 1.37e-04 | 465 | 64 | 7 | M9192 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 1.59e-04 | 111 | 64 | 4 | M45685 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | 1.61e-04 | 477 | 64 | 7 | M40930 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | 1.68e-04 | 644 | 64 | 8 | M10501 | |
| ToppCell | AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.41e-07 | 181 | 64 | 6 | ed0ea67f0607073aedf153f8d1073b35e46127c3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.08e-07 | 198 | 64 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-06 | 160 | 64 | 5 | 6d941e584360975e1fdbb2fc67af8e31f18759d8 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-06 | 174 | 64 | 5 | a8bd1fa08bf061a627529a38e5a23a68b6d80697 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-06 | 174 | 64 | 5 | 7f8f6a15a823809effd37c1a5b09ef19b6d67755 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-06 | 177 | 64 | 5 | 36da06ca9577cdb7c7b5114e604f6546b9765c08 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17|GI_large-bowel / Manually curated celltypes from each tissue | 5.94e-06 | 179 | 64 | 5 | 6359f30005b17dc5b5c4c8f3a6a38c87ccfe4ee9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 184 | 64 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 184 | 64 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 184 | 64 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.97e-06 | 185 | 64 | 5 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 7.35e-06 | 187 | 64 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.74e-06 | 189 | 64 | 5 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 7.74e-06 | 189 | 64 | 5 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.74e-06 | 189 | 64 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 190 | 64 | 5 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 8.78e-06 | 194 | 64 | 5 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 8.78e-06 | 194 | 64 | 5 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | severe-Classical_Monocyte|World / disease stage, cell group and cell class | 9.00e-06 | 195 | 64 | 5 | cf638aac4d57ae0774008920a1a5e9dfd8c73885 | |
| ToppCell | control-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.00e-06 | 195 | 64 | 5 | 55b9052336cab3e769a126ecaeef267d8e7bcaa8 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 9.00e-06 | 195 | 64 | 5 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.00e-06 | 195 | 64 | 5 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.23e-06 | 196 | 64 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.23e-06 | 196 | 64 | 5 | efddf04f32fc01ab2c1dfb5a7ab0931f0fe86eff | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.23e-06 | 196 | 64 | 5 | 782aa9e75ad032627d95dba763a37ae2b1f7f503 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.46e-06 | 197 | 64 | 5 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.46e-06 | 197 | 64 | 5 | ad589eaf49921e128d5eb38173e4b0c4515abeec | |
| ToppCell | severe-Classical_Monocyte|severe / disease stage, cell group and cell class | 9.46e-06 | 197 | 64 | 5 | 1263f141fd03a9294127ab5572893f7ae8b49230 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.46e-06 | 197 | 64 | 5 | 59745f84346efdcb2ab864a84681f043ba4c9b86 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.69e-06 | 198 | 64 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-MAIT|URO / Disease, condition lineage and cell class | 9.69e-06 | 198 | 64 | 5 | 75db638278d4be2b0f406cd8871058a8352c5a86 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.69e-06 | 198 | 64 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.69e-06 | 198 | 64 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 200 | 64 | 5 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 200 | 64 | 5 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Influenza|World / Disease, condition lineage and cell class | 1.02e-05 | 200 | 64 | 5 | df996c35907a1c9194b9e2ca30e81f520ca067f0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 200 | 64 | 5 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.13e-05 | 148 | 64 | 4 | 438fe292d29be0206e1d9fd59ede5f8368f13665 | |
| ToppCell | MS-CD4-CD8_2|MS / Condition, Cell_class and T cell subcluster | 6.29e-05 | 149 | 64 | 4 | 08fb6be5599c5988890c851ce5ac6781c319948e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.62e-05 | 151 | 64 | 4 | e1ffd99001b6a5b795f3367882a9355955c0e569 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.80e-05 | 152 | 64 | 4 | 6aad62b5b5ad2f78c6600f37960338d40628a439 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.51e-05 | 156 | 64 | 4 | 8353f98e7d393d4299ed1da8f66cfbc7176df1b5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.70e-05 | 157 | 64 | 4 | a98d06cef80bfe8481b0940abce2b29675e45812 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD4_CTL|Bac-SEP / Disease, Lineage and Cell Type | 7.89e-05 | 158 | 64 | 4 | 4beed58bf58253253fc7e5009294b35e3bb8eae3 | |
| ToppCell | COPD-Epithelial-PNEC|World / Disease state, Lineage and Cell class | 8.29e-05 | 160 | 64 | 4 | cdea93317b0ebb801ddbe73bca6149ce2c727f16 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-05 | 161 | 64 | 4 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-05 | 161 | 64 | 4 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-05 | 161 | 64 | 4 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-05 | 161 | 64 | 4 | 274838cebdc7af1db32d309dfe42ef7ccd3c190b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-05 | 161 | 64 | 4 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | URO-Lymphocyte-T_NK-MAIT|URO / Disease, Lineage and Cell Type | 9.12e-05 | 164 | 64 | 4 | cb42a70433b3968caca67f7aa98ea536cd90a0bc | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|ILC / Donor, Lineage, Cell class and subclass (all cells) | 9.31e-05 | 61 | 64 | 3 | d0b33a48ee2faf68b270f9279c630437f3e8b20b | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 9.56e-05 | 166 | 64 | 4 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 168 | 64 | 4 | 1df3c8c7a6dceb901805eaba7f86f9943f4f1a9d | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 168 | 64 | 4 | 22fa707689e8d6ca5154103b7374007d644d61c3 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 168 | 64 | 4 | 1586451d437b70b2dffe41d782b694702dcaf50b | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-04 | 170 | 64 | 4 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 171 | 64 | 4 | a474aaed3ca4cacb0ab565c35f25d92a10f531b7 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.07e-04 | 171 | 64 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 1.10e-04 | 172 | 64 | 4 | 1b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 172 | 64 | 4 | 4d04df9776394ea156ed5822f92ae74fdefbaa3d | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-regulatory_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 172 | 64 | 4 | 425970e9ce8943f7e2ba6ca958e7a3a29baa798c | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 172 | 64 | 4 | ca0cc0e92b6cdce5016f18fcb2ec1508cb222502 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 172 | 64 | 4 | 3acf35b774ebc0f9e96299d0bd3e9d03bbf6b90c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-04 | 173 | 64 | 4 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Control-CD4+_T_activated|World / Disease group and Cell class | 1.12e-04 | 173 | 64 | 4 | 12f8e4276b290bb388a56de4c8d8dd60415b2f63 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 173 | 64 | 4 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.12e-04 | 173 | 64 | 4 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 173 | 64 | 4 | 01df9baeedf30e3a4891738554cdd300394dbb96 | |
| ToppCell | Control-CD4+_T_activated|Control / Disease group and Cell class | 1.15e-04 | 174 | 64 | 4 | 2b683e81b315ad22555314433aed5681feb48da8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 174 | 64 | 4 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 174 | 64 | 4 | 919fc124affc69acfd8f575f2c372674f3d2625e | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-04 | 175 | 64 | 4 | 3bdccb4037053795d62ab5b6fcc09cdd406f9b50 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 175 | 64 | 4 | 392123b037ff48c924ebd020ac86891116a2dcd3 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-04 | 175 | 64 | 4 | 770546ddaa49ee482c4c7577ab76efbc6c304a29 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 176 | 64 | 4 | 33323c97afe509147956b8df9f92ca6b0537e604 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 1.20e-04 | 176 | 64 | 4 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 176 | 64 | 4 | 71b3309ddadd035a1224fca4fc5946dc4c0283fe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-04 | 177 | 64 | 4 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 64 | 4 | 7853430fb0d1a18d835e8956777e0616c5d7d412 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 177 | 64 | 4 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 177 | 64 | 4 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-NK_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 64 | 4 | be35bb178fbc149f8a12984c012d98b486325ba9 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 64 | 4 | 8cc74873f4d2d0f81042426a687b01750abc72d2 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 64 | 4 | baf78a8dad55f124f56585f88b10b58c0269680f | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 64 | 4 | 395f005f019aabb18738d3a10a04c37f216deda3 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 64 | 4 | fe0f6a73264632bdd4f9fbc22de2d155ba2bcf8c | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 64 | 4 | 9a5bf67a801826d094f679dd2189b62296c9694f | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 177 | 64 | 4 | 621dd82f1393c961d4dd7a615aa52c9df9e36336 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-04 | 178 | 64 | 4 | c85de851b39cb8ef7ea1866ab64c6a387788273a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-04 | 179 | 64 | 4 | 13d80ae2e43a5daad0aeb5f47338efca2c58800a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-04 | 179 | 64 | 4 | dd3cf8fd10dc257d933a7f45860dc2e244c158b7 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.28e-04 | 179 | 64 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 180 | 64 | 4 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-04 | 180 | 64 | 4 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 180 | 64 | 4 | 6f8fa9fa91cd25b92584972bb34d90c483222f52 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 1.33e-04 | 181 | 64 | 4 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 181 | 64 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.33e-04 | 181 | 64 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.33e-04 | 181 | 64 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| Drug | NSC759576 | 3.15e-09 | 191 | 64 | 9 | CID000003075 | |
| Drug | gadolinium | 4.52e-09 | 199 | 64 | 9 | CID000023982 | |
| Drug | IAA-94 | 1.91e-08 | 61 | 64 | 6 | CID000003667 | |
| Drug | CNS 1145 | 3.34e-08 | 33 | 64 | 5 | CID000190902 | |
| Drug | IHC-64 | 3.34e-08 | 33 | 64 | 5 | CID000162753 | |
| Drug | cyclophorine | CFH ENGASE CACNA2D1 CACNA2D2 ACTN4 APOB TNFAIP3 RYR2 RYR3 ITPR3 | 2.91e-07 | 426 | 64 | 10 | CID000002909 |
| Drug | chloro-m-cresol | 4.21e-07 | 6 | 64 | 3 | CID000012008 | |
| Drug | Cinildipine | 5.12e-07 | 56 | 64 | 5 | CID000002752 | |
| Drug | nilvadipine | 7.26e-07 | 60 | 64 | 5 | CID000004494 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 7.35e-07 | 7 | 64 | 3 | CID009547999 | |
| Drug | Azumoleno | 7.35e-07 | 7 | 64 | 3 | CID000056259 | |
| Drug | Br2BAPTA | 7.35e-07 | 7 | 64 | 3 | CID003081001 | |
| Drug | lamotrigine | 9.05e-07 | 116 | 64 | 6 | CID000003878 | |
| Drug | lercanidipine | 9.28e-07 | 63 | 64 | 5 | CID000065866 | |
| Drug | gallopamil | 1.26e-06 | 67 | 64 | 5 | CID000001234 | |
| Drug | phenformin hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.38e-06 | 198 | 64 | 7 | 21_DN | |
| Drug | AC1L2AC7 | 1.46e-06 | 69 | 64 | 5 | CID000068733 | |
| Drug | bepridil | 1.47e-06 | 126 | 64 | 6 | CID000002351 | |
| Drug | CAS 298-57-7 | 1.94e-06 | 73 | 64 | 5 | CID000002761 | |
| Drug | ethosuximide | 2.08e-06 | 74 | 64 | 5 | CID000003291 | |
| Drug | AC1L1KC5 | CACNA2D1 SACS CACNA2D2 GIMAP5 CAMK1G TNFAIP3 CAMK1 RYR2 RYR3 ITPR3 | 2.53e-06 | 541 | 64 | 10 | CID000005428 |
| Drug | nisoldipine | 2.70e-06 | 78 | 64 | 5 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.87e-06 | 79 | 64 | 5 | CID005287890 | |
| Drug | Fura-2AM | 2.87e-06 | 79 | 64 | 5 | CID000105091 | |
| Drug | R 478 | 3.44e-06 | 11 | 64 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 3.44e-06 | 11 | 64 | 3 | CID003081323 | |
| Drug | manidipine | 7.14e-06 | 95 | 64 | 5 | CID000004008 | |
| Drug | isotetrandrine | 7.90e-06 | 97 | 64 | 5 | CID000005422 | |
| Drug | gabapentin | 8.03e-06 | 169 | 64 | 6 | CID000003446 | |
| Drug | nitrendipine | 8.31e-06 | 98 | 64 | 5 | CID000004507 | |
| Drug | lavendustin A | 8.59e-06 | 171 | 64 | 6 | CID000003894 | |
| Drug | isradipine | 9.17e-06 | 100 | 64 | 5 | CID000003784 | |
| Drug | FPL 64176 | 9.41e-06 | 15 | 64 | 3 | CID000003423 | |
| Drug | Gvapspat amide | 9.41e-06 | 15 | 64 | 3 | CID000125015 | |
| Drug | riluzole | 9.49e-06 | 174 | 64 | 6 | CID000005070 | |
| Drug | loperamide | 1.16e-05 | 105 | 64 | 5 | CID000003954 | |
| Drug | NSC7524 | 1.23e-05 | 182 | 64 | 6 | CID000005657 | |
| Drug | thiopental | 1.59e-05 | 112 | 64 | 5 | CID003000715 | |
| Drug | baclofen | 1.61e-05 | 191 | 64 | 6 | CID000002284 | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 1.61e-05 | 191 | 64 | 6 | 7376_DN | |
| Drug | diamino sulfate | 1.71e-05 | 193 | 64 | 6 | CID006327663 | |
| Drug | Sulfaguanidine [57-67-0]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 1495_DN | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 6011_UP | |
| Drug | AC1NBU2S | 1.97e-05 | 117 | 64 | 5 | CID004473765 | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.98e-05 | 198 | 64 | 6 | 3681_DN | |
| Drug | tolbutamide; Up 200; 100uM; MCF7; HG-U133A | 2.03e-05 | 199 | 64 | 6 | 142_UP | |
| Drug | Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.09e-05 | 200 | 64 | 6 | 7483_UP | |
| Drug | menthol glucuronide | 2.33e-05 | 3 | 64 | 2 | CID000133208 | |
| Drug | cis-diammineplatinum(II | 2.33e-05 | 3 | 64 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 2.33e-05 | 3 | 64 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 2.33e-05 | 3 | 64 | 2 | CID000127713 | |
| Drug | aminodantrolene | 2.33e-05 | 3 | 64 | 2 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 2.33e-05 | 3 | 64 | 2 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 2.33e-05 | 3 | 64 | 2 | CID005748312 | |
| Drug | indo-1/AM | 2.72e-05 | 21 | 64 | 3 | CID000123918 | |
| Drug | pimozide | 2.92e-05 | 127 | 64 | 5 | CID000016362 | |
| Drug | emiglitate | 3.14e-05 | 22 | 64 | 3 | CID000072004 | |
| Drug | fura 2 | 3.38e-05 | 65 | 64 | 4 | CID000057054 | |
| Drug | pioglitazone | 3.57e-05 | 326 | 64 | 7 | CID000004829 | |
| Drug | lanthanum | 4.06e-05 | 136 | 64 | 5 | CID000023926 | |
| Drug | PCB74 | 4.65e-05 | 4 | 64 | 2 | CID000036218 | |
| Drug | Gabapentin | 4.65e-05 | 4 | 64 | 2 | DB00996 | |
| Drug | 148504-47-6 | 4.65e-05 | 4 | 64 | 2 | CID006444275 | |
| Drug | SC 38249 | 4.65e-05 | 4 | 64 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 4.65e-05 | 4 | 64 | 2 | CID000035682 | |
| Drug | T0702 | 4.66e-05 | 25 | 64 | 3 | CID000005908 | |
| Drug | AC1L1GTT | 4.92e-05 | 233 | 64 | 6 | CID000003837 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 4.92e-05 | 233 | 64 | 6 | CID000005114 | |
| Drug | St. Thomas' Hospital cardioplegic solution | 4.99e-05 | 142 | 64 | 5 | ctd:C041711 | |
| Drug | nimodipine | 5.51e-05 | 145 | 64 | 5 | CID000004497 | |
| Drug | nicardipine | 5.51e-05 | 145 | 64 | 5 | CID000004473 | |
| Drug | Dantrolene-13C3 | 5.51e-05 | 145 | 64 | 5 | CID000002951 | |
| Drug | genistein | PCSK1 CACNA2D1 TIMP2 CACNA2D2 GIMAP5 APOB TNFAIP3 RYR2 IL7R RYR3 ITPR3 NEDD4 | 5.65e-05 | 1117 | 64 | 12 | CID005280961 |
| Drug | Androgen Antagonists | 5.94e-05 | 75 | 64 | 4 | ctd:D000726 | |
| Drug | Bay K 8644 | 6.47e-05 | 150 | 64 | 5 | CID000002303 | |
| Drug | monomethyl phthalate | PCSK1 ENGASE FZR1 IL16 ATP6V1H CTSC LRRK2 APOB ACOT2 SULT1C4 ITPR3 | 6.59e-05 | 957 | 64 | 11 | ctd:C517284 |
| Drug | quinocetone | 6.95e-05 | 248 | 64 | 6 | ctd:C502851 | |
| Drug | procaine | 7.11e-05 | 153 | 64 | 5 | CID000004914 | |
| Drug | lindane | 7.33e-05 | 154 | 64 | 5 | CID000000727 | |
| Drug | 2,4-xylidinothiazoline | 8.15e-05 | 30 | 64 | 3 | CID000099296 | |
| Drug | N-methyl-DL-aspartic acid | 8.57e-05 | 655 | 64 | 9 | CID000004376 | |
| Drug | XeC compound | 9.25e-05 | 84 | 64 | 4 | CID000005701 | |
| Drug | propionate | 9.40e-05 | 262 | 64 | 6 | CID000001032 | |
| Drug | NSC717865 | 1.05e-04 | 387 | 64 | 7 | CID000005372 | |
| Drug | cobalt-60 | 1.10e-04 | 390 | 64 | 7 | CID000061492 | |
| Drug | felodipine | 1.14e-04 | 169 | 64 | 5 | CID000003333 | |
| Drug | isohexadecane | 1.16e-04 | 6 | 64 | 2 | CID000020414 | |
| Drug | MBED | 1.16e-04 | 6 | 64 | 2 | CID000129958 | |
| Drug | AC1O528X | 1.16e-04 | 6 | 64 | 2 | CID006475857 | |
| Drug | copper phosphate | 1.16e-04 | 6 | 64 | 2 | CID000024942 | |
| Drug | NSC114784 | 1.16e-04 | 6 | 64 | 2 | CID000419425 | |
| Drug | aldosterone | 1.23e-04 | 397 | 64 | 7 | CID000005839 | |
| Drug | 1ct8 | 1.27e-04 | 173 | 64 | 5 | CID000444888 | |
| Drug | cobalt sulfate | 1.30e-04 | 35 | 64 | 3 | ctd:C026305 | |
| Drug | AC1NUZ8M | 1.32e-04 | 92 | 64 | 4 | CID000073211 | |
| Drug | papaverine | 1.37e-04 | 176 | 64 | 5 | CID000004680 | |
| Drug | 4-nitrophenol | 1.41e-04 | 177 | 64 | 5 | CID000000980 | |
| Drug | 9,10-Dimethyl-1,2-benzanthracene | CACNA2D1 NRXN1 TIMP2 GIMAP5 AGL CAPN3 PDE4DIP RABGEF1 ACTN4 DNAJC2 TFRC | 1.45e-04 | 1046 | 64 | 11 | ctd:D015127 |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.53e-04 | 180 | 64 | 5 | 4344_UP | |
| Drug | mag-fura-2 | 1.54e-04 | 37 | 64 | 3 | CID000123839 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.34e-05 | 3 | 63 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.34e-05 | 3 | 63 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | interleukin-16 measurement | 1.34e-05 | 3 | 63 | 2 | EFO_0801717 | |
| Disease | caudate volume change measurement, age at assessment | 2.62e-05 | 27 | 63 | 3 | EFO_0008007, EFO_0021491 | |
| Disease | neurexin-3-beta measurement | 2.68e-05 | 4 | 63 | 2 | EFO_0020597 | |
| Disease | Autism Spectrum Disorders | 3.36e-05 | 85 | 63 | 4 | C1510586 | |
| Disease | Myocardial Ischemia | 3.79e-05 | 176 | 63 | 5 | C0151744 | |
| Disease | galectin-7 measurement | 6.69e-05 | 6 | 63 | 2 | EFO_0022034 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.60e-04 | 9 | 63 | 2 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.60e-04 | 9 | 63 | 2 | EFO_0802127 | |
| Disease | bone morphogenetic protein 7 measurement | 2.00e-04 | 10 | 63 | 2 | EFO_0020187 | |
| Disease | cytochrome p450 3a4 measurement | 2.44e-04 | 11 | 63 | 2 | EFO_0020303 | |
| Disease | respiratory system disease | 2.66e-04 | 145 | 63 | 4 | EFO_0000684 | |
| Disease | waist circumference | 3.08e-04 | 429 | 63 | 6 | EFO_0004342 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.18e-04 | 152 | 63 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | X-24588 measurement | 3.45e-04 | 13 | 63 | 2 | EFO_0800898 | |
| Disease | retinol dehydrogenase 16 measurement | 3.45e-04 | 13 | 63 | 2 | EFO_0802007 | |
| Disease | angiopoietin-related protein 1 measurement | 6.71e-04 | 18 | 63 | 2 | EFO_0801382 | |
| Disease | Schizophrenia | 6.71e-04 | 18 | 63 | 2 | cv:C0036341 | |
| Disease | Cannabis use, age at onset | 7.49e-04 | 19 | 63 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | Omenn Syndrome | 7.49e-04 | 19 | 63 | 2 | C2700553 | |
| Disease | coagulation factor measurement | 8.32e-04 | 20 | 63 | 2 | EFO_0004634 | |
| Disease | Severe Combined Immunodeficiency | 8.32e-04 | 20 | 63 | 2 | C0085110 | |
| Disease | tissue factor measurement | 9.18e-04 | 21 | 63 | 2 | EFO_0010623 | |
| Disease | cortical thickness change measurement, age at assessment | 1.10e-03 | 23 | 63 | 2 | EFO_0008007, EFO_0021501 | |
| Disease | response to antineoplastic agent | 1.26e-03 | 99 | 63 | 3 | GO_0097327 | |
| Disease | Early Pregnancy Loss | 1.66e-03 | 109 | 63 | 3 | C3830362 | |
| Disease | Spontaneous abortion | 1.66e-03 | 109 | 63 | 3 | C0000786 | |
| Disease | Miscarriage | 1.66e-03 | 109 | 63 | 3 | C4552766 | |
| Disease | Abortion, Tubal | 1.66e-03 | 109 | 63 | 3 | C0000822 | |
| Disease | muscular atrophy (biomarker_via_orthology) | 1.76e-03 | 29 | 63 | 2 | DOID:767 (biomarker_via_orthology) | |
| Disease | aortic measurement | 2.05e-03 | 251 | 63 | 4 | EFO_0020865 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WNNSSFDDDHKIKFQ | 671 | Q99569 | |
| KRFHWEQDQIAHMKN | 326 | Q9UG63 | |
| KDKNRHDKDQQHRQW | 66 | Q9BQE5 | |
| AENFQKAHRWQDNIK | 141 | Q9NY47 | |
| WAEKFKVLASNRTHQ | 851 | Q9NY47 | |
| KNVNVQNFHISWKDG | 181 | O43707 | |
| AQVDAWKQLQTFFHK | 456 | P49753 | |
| FKHLWKQVAQNLDRF | 291 | P30038 | |
| NARTKNDFTWFKLND | 516 | P08603 | |
| SHNFNEDRWRKAALK | 1696 | Q8TDJ6 | |
| KTWNHFSDNEAERVK | 361 | Q99543 | |
| AKFRKSDTNEWNKND | 6 | Q9P0K7 | |
| EEYHKARQKQIQEDW | 41 | Q9UJ41 | |
| WTDKNNEHHEKSVRQ | 696 | Q14573 | |
| FQHQEDSKKWRNRFS | 76 | Q96TA1 | |
| VKWHFNINQKRFSKA | 116 | Q6P4D5 | |
| EKTKNNWAERDHFVS | 131 | Q9Y6F1 | |
| DVDVNDWREHTKYKN | 1201 | P46934 | |
| FENQHKERTQEKWGF | 421 | Q8N6Q8 | |
| KQSANWNKFERNNTD | 1716 | Q8IVV2 | |
| QAVENTKFGKERHQW | 456 | Q14005 | |
| KFNDNAWHDVKVTRN | 336 | Q9Y4C0 | |
| RKNKHVQEAACWALN | 361 | Q5S007 | |
| DVAYRQEKDENKWTH | 166 | P16871 | |
| KFNDNAWHDVKVTRN | 361 | Q9ULB1 | |
| KSKWRQAFNAAAVVH | 301 | Q96NX5 | |
| HKQELRENESNWAYK | 256 | Q96F15 | |
| TWQKSKDLQAQAFAH | 891 | Q5T6X5 | |
| SKWKQAFNATAVVRH | 301 | Q14012 | |
| NWSVNFHRINENEKS | 56 | Q9UM11 | |
| LNSFNWERQVSHAKE | 2126 | P04114 | |
| KVQAAHQWREDFASN | 106 | P54289 | |
| DHNFVKAINAIQKSW | 171 | P53634 | |
| FQHASEDARKTINQW | 121 | P30740 | |
| KWQDELNQHNRVFFD | 281 | Q8NFI3 | |
| QTRWKHQVSDNKDSF | 131 | Q13002 | |
| WSFVDKDEKARLQHQ | 376 | P20807 | |
| ARNDLHKNANEWVCF | 4461 | Q9NZJ4 | |
| WSKSHNFKREEQNFV | 3406 | Q92736 | |
| AWDHFSKAQRKNIDI | 361 | Q8TC92 | |
| AKAAEVRANKVNWQS | 21 | Q9UI12 | |
| ERIQHWKKVDNDYNA | 46 | O94763 | |
| LNQFSRAVAAKWKDD | 16 | P04808 | |
| EFSKTWEFKNHNVAV | 81 | Q5SGD2 | |
| VWRDQHFVKIQVKDS | 181 | P02786 | |
| KTFQGHTNEVNAIKW | 406 | O60907 | |
| NKNADNDWFRLESNK | 46 | Q9Y3C8 | |
| DWDSRFANFRNNKDK | 1466 | Q96T58 | |
| NHKWKNDNSRQRAVT | 296 | Q9UHK0 | |
| HEYKKWQENSEQGRR | 351 | P21580 | |
| FKEKHHSWFINQSVQ | 66 | Q5TBB1 | |
| LWCKSHNFKREEQNF | 3301 | Q15413 | |
| WKKHFTVAQNERFDE | 271 | O75897 | |
| DWVTEKNINGHQAKF | 176 | P16035 | |
| QHSNEYVVRNKKLWD | 1086 | P53804 | |
| KAFAHAQWKAQVRSI | 91 | O60656 | |
| EQQWISHTFDHINKR | 1866 | Q6ZT12 | |
| DKAFRWKSQLNAHQK | 266 | Q6PF04 | |
| NAKKNWQRIQEHFFF | 1331 | Q13395 | |
| NWDFRKEADLQVHVK | 756 | Q2M1K9 | |
| SKHQAADNKAAAEWL | 261 | Q7RTV3 | |
| LQANQHDVAKFWSDI | 281 | Q6ZT98 | |
| EWNRKIQDNFEKLFH | 1326 | P35573 | |
| AAAHESEQQKEASWK | 381 | Q5VU43 | |
| ALNSAKAKRQFVNEW | 21 | P29120 |